Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-23 SCHACHLE JOSEPH K Chief Operating Officer Sale −4,767 $3.57 $17K 286,673
2026-07-23 SCHACHLE JOSEPH K Chief Operating Officer Sale −4,644 $2.94 $14K 291,440
2026-04-23 SCHACHLE JOSEPH K Chief Operating Officer Sale −4,697 $5.22 $25K 296,084
2026-03-16 SCHACHLE JOSEPH K Chief Operating Officer Sale −3,719 $5.25 $20K 300,781
2026-01-22 SCHACHLE JOSEPH K Chief Operating Officer Grant or award +250,000 304,500
2025-03-13 SCHACHLE JOSEPH K Chief Operating Officer Grant or award +52,500 54,500
2025-03-13 SCHACHLE JOSEPH K Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +52,500 52,500
2024-03-21 SCHACHLE JOSEPH K Chief Operating Officer Purchase +2,000 $2.05 $4K 2,000
2023-11-27 SCHACHLE JOSEPH K Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +300,000 300,000

Page 1 of 1 · 9 trades